Madrigal Pharmaceuticals (MDGL) Stock
Madrigal Pharmaceuticals (MDGL) closed at $421.99 on Nov 17, 2026; its Tenet Score is 32 of 100 against 340 Healthcare peers.
23 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $421.99
- Nov 17, 2026
- Market cap
- $9.8B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 353.54 – 615.00
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 32/100
- Weak · 340 Healthcare peers
Industry: Drugs
Madrigal Pharmaceuticals Inc scores 32/100. Weak. Value is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 32 is built from 3 of 4 pillars, from 50% of its inputs. Growth is left out because no growth rate could be measured.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ~ Reversal Evidence
13F flows & insider trades land here.
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetir…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Bio-Techne CorpTECH | 51 | $11.4B |
| Biomarin Pharmaceutical Inc.BMRN | 43 | $11.2B |
| Halozyme Therapeutics Inc.HALO | 71 | $11.0B |
| Kymera Therapeutics IncKYMR | 41 | $10.7B |
| Repligen Corp.RGEN | 49 | $10.4B |
| TG Therapeutics IncTGTX | 43 | $9.6B |
| Spyre Therapeutics Inc.SYRE | 43 | $9.4B |
| Krystal Biotech IncKRYS | 66 | $8.8B |
| Praxis Precision Medicines IncPRAX | 46 | $8.7B |
| Protagonist Therapeutics IncPTGX | 65 | $8.1B |
Common questions
What sector and industry is Madrigal Pharmaceuticals in?
Madrigal Pharmaceuticals is in the Healthcare sector and the Drugs industry.
What is Madrigal Pharmaceuticals' Tenet Score?
Madrigal Pharmaceuticals' Tenet Score is 32 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




